Literature DB >> 4007018

Vascular structure of the C3H mammary carcinoma, the B16 melanoma and the Lewis lung carcinoma in syngeneic, conventional mice and congenitally athymic mice.

O V Solesvik, E K Rofstad, T Brustad.   

Abstract

The vascular system of three commonly used murine experimental tumours, the C3H mammary carcinoma, the B16 melanoma and the Lewis lung carcinoma, in syngeneic (C3D2F1/Bom or C57BL/6J/Bom) and athymic (BALB/c/nu/nu/Bom) mice was studied. The main vascular characteristics of each tumour, i.e. the mean vessel diameter, the total vessel volume and the distribution of the total vessel volume among vessels with different diameters, did not change upon transplantation from conventional to athymic mice. However, the length of vessels with diameters in the range 5-15 micron was for all tumours shorter in athymic than in conventional mice. The vascular volume of the B16 melanoma per unit histologically intact tumour volume in athymic mice (0.040 +/- 0.004) was considerably larger than that of five human melanoma xenografts previously studied (0.009 +/- 0.001 to 0.022 +/- 0.002). This difference was mainly due to occurrence of vessels with diameters in the range 55-145 micron in the B16 melanoma; vessels which were generally not observed in the human melanoma xenografts.

Entities:  

Mesh:

Year:  1985        PMID: 4007018     DOI: 10.1016/0277-5379(85)90044-6

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  2 in total

1.  Tumor blood flow differs between mouse strains: consequences for vasoresponse to photodynamic therapy.

Authors:  Rickson C Mesquita; Sung Wan Han; Joann Miller; Steven S Schenkel; Andrew Pole; Tatiana V Esipova; Sergei A Vinogradov; Mary E Putt; Arjun G Yodh; Theresa M Busch
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

2.  Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours.

Authors:  K A Smith; S A Hill; A C Begg; J Denekamp
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.